Nature’s most effective search engine

Pipeline

Program	Target	Discovery	Pre-clinical	Phase 1	Comment
ATLX-1282 ALS/Neuro	Undisclosed				IND May ‘25 Partnered
ATLX-2199 Muscle atrophy	Undisclosed
ATLX-2199 Parkinson’s disease	Undisclosed
ATLX-1088 Alzheimer’s disease	CD33
Earlier discovery programs	Multiple
Discovery deal	Multiple				Partnered

Discovery	Pre-clinical	Phase 1
ATLX-1282 ALS/Neuro - Undisclosed
IND May ‘25 Partnered

ATLX-2199 Muscle atrophy - Undisclosed


ATLX-2199 Parkinson’s disease - Undisclosed


ATLX-1088 Alzheimer’s disease - CD33


Earlier discovery programs - Multiple


Discovery deal - Multiple
Partnered

● Metabolic, immunology, oncology and other
● Neurology

@media (min-width:1042px){ #menu-primary-nav .sub-menu{ transition:transform 233ms 610ms, opacity 89ms calc(233ms + 610ms - 89ms) linear; } } @media (max-width:1041px){ #primary-navigation .menu-primary-nav-container{ -webkit-transition: -webkit-transform .233s ease-out, opacity .233s linear; transition: transform .233s ease-out, opacity .233s linear; } }